Anaphylatoxin

WikiDoc Resources for Anaphylatoxin
Articles
Most recent articles on Anaphylatoxin Most cited articles on Anaphylatoxin Review articles on Anaphylatoxin Articles on Anaphylatoxin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Anaphylatoxin Images of Anaphylatoxin Photos of Anaphylatoxin Podcasts & MP3s on Anaphylatoxin Videos on Anaphylatoxin
Evidence Based Medicine
Cochrane Collaboration on Anaphylatoxin Bandolier on Anaphylatoxin TRIP on Anaphylatoxin
Clinical Trials
Ongoing Trials on Anaphylatoxin at Clinical Trials.gov Trial results on Anaphylatoxin Clinical Trials on Anaphylatoxin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Anaphylatoxin NICE Guidance on Anaphylatoxin NHS PRODIGY Guidance FDA on Anaphylatoxin CDC on Anaphylatoxin
Books
Books on Anaphylatoxin
News
Anaphylatoxin in the news Be alerted to news on Anaphylatoxin News trends on Anaphylatoxin
Commentary
Blogs on Anaphylatoxin
Definitions
Definitions of Anaphylatoxin
Patient Resources / Community
Patient resources on Anaphylatoxin Discussion groups on Anaphylatoxin Patient Handouts on Anaphylatoxin Directions to Hospitals Treating Anaphylatoxin Risk calculators and risk factors for Anaphylatoxin
Healthcare Provider Resources
Symptoms of Anaphylatoxin Causes & Risk Factors for Anaphylatoxin Diagnostic studies for Anaphylatoxin Treatment of Anaphylatoxin
Continuing Medical Education (CME)
CME Programs on Anaphylatoxin
International
Anaphylatoxin en Espanol Anaphylatoxin en Francais
Business
Anaphylatoxin in the Marketplace Patents on Anaphylatoxin
Experimental / Informatics
List of terms related to Anaphylatoxin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Anaphylatoxins, or anaphylotoxins, are fragments (C3a, C4a or C5a) that are produced during the pathways of the complement system.

Direct and indirect functions

Most notable is the ability to trigger degranulation of (release of substances from) mast cells or basophils, which is an important part of the immune system in all kinds of inflammation and especially as part of defense against parasites. If the degranulation is too strong, it can cause allergic reactions.

Anaphylatoxins indirectly mediate:

• spasms of smooth muscle cells, for example bronchospasms
• increase in the permeability of blood capillaries
• chemotaxis — receptor-mediated movement of leukocytes in the direction of the increasing concentration of anaphylatoxins

Examples

Important anaphylatoxins:

• C3a is not as strong as C5a, but stronger than C4a and can trigger degranulation of Mast-cells and serve as a chemotactic targeting molecule for eosinophile granulocytes.
• C4a is the least active anaphylatoxin
• C5a is the strongest toxin in the row, it is a very strong mediator of inflammation.
  • co-stimulation of C3b at times of phagocytosis (not possible without C5a).
  • Chemotactor and activator for granulocytes in general and macrophages
  • stimulates respiratory burst in Neutrophils
  • increases vascular permeability
  • contracts smooth muscle cells
  • activates mastcells to churn out Histamine and TNF-Alpha

Terminology

Although some drugs (morphine, codeine, synthetic ACTH) and some neurotransmitters (norepinephrine, substance P) are important mediators of degranulation of mast cells or basophils, they are generally not called anaphylatoxins. This term is reserved only for fragments of the complement.

See also

• Allergy
• Anaphylaxis
• Complement system
• Inflammation
• Immune system
• Nervous system

External links

• Anaphylatoxin at the US National Library of Medicine Medical Subject Headings (MeSH)
• Template:EMedicineDictionary